Nasdaq:US$19.60 (-0.30) | HKEX:HK$31.35 (-0.05) | AIM:£3.13 (-0.02)
搜索结果
上一篇文章   |   下一篇文章
公告及新闻稿, 肿瘤学 / 免疫学 | 2006-07-04

Chi-Med plans to broaden clinical trials of its leading oncology drug candidate